World of DTC Marketing
FEBRUARY 21, 2022
A new study estimates the causal effects of coupons for branded drugs without bioequivalent generics using variation in coupon introductions over time and comparing differential responses across enrollees in commercial and Medicare Advantage plans. ” More checks from PhRMA to politicians are coming up.
XTalks
FEBRUARY 8, 2021
While there are currently six biosimilars for AbbVie’s Humira (adalimumab) that have been approved by the regulator, the company’s patents prevent biosimilars from being launched until 2023. The regulator allows biosimilars to show slight differences in clinically inactive components of a product.
Pharmaceutical Technology
JULY 25, 2022
For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. Adding to this, Schulman says pharmacy benefit managers (PBMs) make it challenging to access lower-cost products. The only way forward for generics producers.
Expert insights. Personalized for you.
218 
Let's personalize your content